Made Scientific and Pluristyx Launch Integrated iPSC Development & Manufacturing Partnership to Advance Next-Generation iPSC-derived Cell Therapies
Summary
Made Scientific and Pluristyx formed a strategic partnership to combine Pluristyx’s clinical-grade iPSC platform with Made Scientific’s CDMO services. The deal gives therapy developers a single path from iPSC starting material through GMP manufacturing and commercial supply. The companies say the integration reduces licensing, qualification, and regulatory work while speeding programs toward IND and lowering total cost. The partnership also extends to custom cell line differentiation and master or working cell bank manufacturing for iNK, iMSC, and other derivatives.
Classifications
industries
Fintech & Banking
applications
Content Management
AskAI Classifications
Labels
No AI classifications detected